CLINICAL_TRIALS
trial_result
· 2021-09-10
Clinical Trial Update: A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine [NA]
Summary
A completed pilot study evaluating immunogenicity of candidate PSA peptides for a prostate cancer vaccine; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Arkansas | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2021-09-10